Daclizumab Versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients
Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2008101037
Full Text
Open PDFAbstract
Available in full text
Date
May 21, 2009
Authors
Publisher
American Society of Nephrology (ASN)